Skip to search formSkip to main contentSkip to account menu

WAY 163909

Known as: WAY-163909, WAY163909 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The serotonin subtype 2C (5HT2C) receptor is an emerging and promising drug target to treat several disorders of the human… 
Highly Cited
2013
Highly Cited
2013
Relapse to cocaine dependence, even after extended abstinence, involves a number of liability factors including impulsivity… 
Review
2010
Review
2010
Serotonin 2C receptors are G protein-coupled receptors expressed by GABAergic, glutamatergic, and dopaminergic neurons… 
2008
2008
Introduction5-HT2C agonists, by decreasing mesolimbic dopamine without affecting nigrostriatal dopamine, are predicted to have… 
Highly Cited
2007
Highly Cited
2007
Serotonin-2C (5-HT2C) receptor antagonists and agonists have been shown to affect dopamine (DA) neurotransmission, with agonists… 
Highly Cited
2007
Highly Cited
2007
RationaleActivation of one or more of the serotonin (5-HT) receptors may play a role in mediating the antidepressant effects of… 
Review
2006
Review
2006
The 5-HT(2C) receptor subtype has been implicated in a wide variety of conditions including obesity, anxiety, depression… 
Highly Cited
2005
Highly Cited
2005
The pharmacological profile of WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi…